<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC5776911/results/search/disease/results.xml">
  <result pre="effect of medicinal products, or occurrence or progression mechanism of" exact="atopic dermatitis" post="(AD), a pruritic and persistent inflammatory skin disease. The"/>
  <result pre="of medicinal products, or occurrence or progression mechanism of atopic" exact="dermatitis" post="(AD), a pruritic and persistent inflammatory skin disease. The"/>
  <result pre="group compared with other control groups. These results suggest that" exact="suppression" post="of T H1 cell-mediated immune response could be reflected"/>
  <result pre="disturbance of keratinocyte integrity might evoke a compensatory mechanism. Atopic" exact="dermatitis" post="Murine model Filaggrin IL-18 TNFα Gene expression INTRODUCTION Human"/>
  <result pre="dermatitis Murine model Filaggrin IL-18 TNFα Gene expression INTRODUCTION Human" exact="atopic dermatitis" post="(AD) is the most prevalent inflammatory skin disease characterized"/>
  <result pre="Murine model Filaggrin IL-18 TNFα Gene expression INTRODUCTION Human atopic" exact="dermatitis" post="(AD) is the most prevalent inflammatory skin disease characterized"/>
  <result pre="been extensively evaluated. NC/Nga mice were reported to develop spontaneous" exact="dermatitis" post="resembling human AD on their faces under conventional environmental"/>
  <result pre="and compared with control mice. MATERIALS AND METHODS Animals and" exact="atopic dermatitis" post="induction Specific pathogen free 4 week old male BALB/c"/>
  <result pre="compared with control mice. MATERIALS AND METHODS Animals and atopic" exact="dermatitis" post="induction Specific pathogen free 4 week old male BALB/c"/>
  <result pre="of Daegu’s IACUC (IACUC-2010-33). The detailed method for induction of" exact="atopic dermatitis" post="like immune alterations is described at our previous reports"/>
  <result pre="Daegu’s IACUC (IACUC-2010-33). The detailed method for induction of atopic" exact="dermatitis" post="like immune alterations is described at our previous reports"/>
  <result pre="Significantly higher induction of filaggrin protein expression in mice with" exact="atopic dermatitis" post="Since filaggrin is considered a key component for epidermal"/>
  <result pre="higher induction of filaggrin protein expression in mice with atopic" exact="dermatitis" post="Since filaggrin is considered a key component for epidermal"/>
  <result pre="17), level of filaggrin protein expression was examined following the" exact="atopic dermatitis" post="induction and compared with the AOO vehicle control or"/>
  <result pre="level of filaggrin protein expression was examined following the atopic" exact="dermatitis" post="induction and compared with the AOO vehicle control or"/>
  <result pre="(1.70 ± 0.11) for the skin tissues from mice with" exact="atopic dermatitis" post="than the vehicle control (1.02 ± 0.05) or the"/>
  <result pre="± 0.11) for the skin tissues from mice with atopic" exact="dermatitis" post="than the vehicle control (1.02 ± 0.05) or the"/>
  <result pre="expression of IL-18 and TNF-α mRNA transcript in mice with" exact="atopic dermatitis" post="Since IL-13 is known to be an important player"/>
  <result pre="of IL-18 and TNF-α mRNA transcript in mice with atopic" exact="dermatitis" post="Since IL-13 is known to be an important player"/>
  <result pre="T H2-mediated immune response, which is a central dogma for" exact="atopic dermatitis" post="occurrence ( 18), mRNA expression level of IL-13 was"/>
  <result pre="H2-mediated immune response, which is a central dogma for atopic" exact="dermatitis" post="occurrence ( 18), mRNA expression level of IL-13 was"/>
  <result pre="level of IL-13 was evaluated in skin tissues after the" exact="atopic dermatitis" post="induction ( Fig. 2A, left). IL-18 mRNA expression was"/>
  <result pre="of IL-13 was evaluated in skin tissues after the atopic" exact="dermatitis" post="induction ( Fig. 2A, left). IL-18 mRNA expression was"/>
  <result pre="is one of participants in T H1-mediated immune responses including" exact="allergic contact dermatitis," post="a typical type-4 hypersensitivity reaction ( 19). In addition,"/>
  <result pre="one of participants in T H1-mediated immune responses including allergic" exact="contact dermatitis," post="a typical type-4 hypersensitivity reaction ( 19). In addition,"/>
  <result pre="H1-mediated immune responses including allergic contact dermatitis, a typical type-4" exact="hypersensitivity" post="reaction ( 19). In addition, TNF-α was also investigated"/>
  <result pre="(0.31 ± 0.02) for the skin tissues from mice with" exact="atopic dermatitis" post="than the vehicle control (0.50 ± 0.03) or the"/>
  <result pre="± 0.02) for the skin tissues from mice with atopic" exact="dermatitis" post="than the vehicle control (0.50 ± 0.03) or the"/>
  <result pre="(0.46 ± 0.02) for the skin tissues from mice with" exact="atopic dermatitis" post="than the vehicle control (0.58 ± 0.03), but no"/>
  <result pre="± 0.02) for the skin tissues from mice with atopic" exact="dermatitis" post="than the vehicle control (0.58 ± 0.03), but no"/>
  <result pre="to be well correlated with susceptibility to or pathogenesis of" exact="atopic dermatitis" post="in human subjects ( 2, 17, 22). Epidermal expression"/>
  <result pre="be well correlated with susceptibility to or pathogenesis of atopic" exact="dermatitis" post="in human subjects ( 2, 17, 22). Epidermal expression"/>
  <result pre="of filaggrin protein expression in the skin of mice with" exact="atopic dermatitis" post="through DNCB application ( Fig. 1) is unexpected. A"/>
  <result pre="filaggrin protein expression in the skin of mice with atopic" exact="dermatitis" post="through DNCB application ( Fig. 1) is unexpected. A"/>
  <result pre="for compensation of reduced filaggrin level at early stage of" exact="atopic dermatitis" post="induction in the DNCB-mediated atopic dermatitis induction model. Since"/>
  <result pre="compensation of reduced filaggrin level at early stage of atopic" exact="dermatitis" post="induction in the DNCB-mediated atopic dermatitis induction model. Since"/>
  <result pre="at early stage of atopic dermatitis induction in the DNCB-mediated" exact="atopic dermatitis" post="induction model. Since the model is considered to reflect"/>
  <result pre="early stage of atopic dermatitis induction in the DNCB-mediated atopic" exact="dermatitis" post="induction model. Since the model is considered to reflect"/>
  <result pre="the predominance of T H-2-mediated response in acute phase of" exact="atopic dermatitis" post="progression ( 10, 11, 13), a feed-back mechanism as"/>
  <result pre="predominance of T H-2-mediated response in acute phase of atopic" exact="dermatitis" post="progression ( 10, 11, 13), a feed-back mechanism as"/>
  <result pre="of filaggrin protein may be an indicator for aggravation of" exact="atopic dermatitis" post="pathogenesis. This speculation has been made for skin tissues"/>
  <result pre="filaggrin protein may be an indicator for aggravation of atopic" exact="dermatitis" post="pathogenesis. This speculation has been made for skin tissues"/>
  <result pre="the present murine model, which induces pathophysiological changes resembling human" exact="atopic dermatitis," post="may not be implied with genetic alteration leading to"/>
  <result pre="in the skin tissues of mice treated with DNCB for" exact="atopic dermatitis" post="induction ( Fig. 2). Proinflammatory activity of IL-18 has"/>
  <result pre="the skin tissues of mice treated with DNCB for atopic" exact="dermatitis" post="induction ( Fig. 2). Proinflammatory activity of IL-18 has"/>
  <result pre="predominance of T H1-mediated immune reactivities in chronic stage of" exact="atopic dermatitis" post="( 3, 28, 29). Since the present murine model"/>
  <result pre="of T H1-mediated immune reactivities in chronic stage of atopic" exact="dermatitis" post="( 3, 28, 29). Since the present murine model"/>
  <result pre="( 3, 28, 29). Since the present murine model for" exact="atopic dermatitis" post="occurrence is considered rather an acute induction model through"/>
  <result pre="3, 28, 29). Since the present murine model for atopic" exact="dermatitis" post="occurrence is considered rather an acute induction model through"/>
  <result pre="and two time challenge with DNCB for 2 weeks, the" exact="suppression" post="of IL-18 mRNA transcript could be evoked by a"/>
  <result pre="by a systemic predominance of T H2 response during the" exact="atopic dermatitis" post="induction in mice ( 10, 11, 13). Meanwhile, it"/>
  <result pre="a systemic predominance of T H2 response during the atopic" exact="dermatitis" post="induction in mice ( 10, 11, 13). Meanwhile, it"/>
  <result pre="skin homeostasis through enhancement of inflammatory cell infiltration in human" exact="atopic dermatitis" post="( 1, 18, 28). Concomitant up-regulation of both IL-4"/>
  <result pre="homeostasis through enhancement of inflammatory cell infiltration in human atopic" exact="dermatitis" post="( 1, 18, 28). Concomitant up-regulation of both IL-4"/>
  <result pre="from axillary lymph node T cells in the mice with" exact="atopic dermatitis" post="compared to the control mice in our murine model"/>
  <result pre="axillary lymph node T cells in the mice with atopic" exact="dermatitis" post="compared to the control mice in our murine model"/>
  <result pre="chronic AD skin lesions ( 36). Considering these findings together," exact="atopic dermatitis" post="induced in our murine model may be in rather"/>
  <result pre="AD skin lesions ( 36). Considering these findings together, atopic" exact="dermatitis" post="induced in our murine model may be in rather"/>
  <result pre="IL-13 mRNA expression in the skin tissues of mice with" exact="atopic dermatitis" post="could result in the up-regulation of filaggrin protein instead"/>
  <result pre="mRNA expression in the skin tissues of mice with atopic" exact="dermatitis" post="could result in the up-regulation of filaggrin protein instead"/>
  <result pre="some characteristic features to the published list of the human" exact="atopic dermatitis" post="like immune or pathophysiological features in the murine model,"/>
  <result pre="characteristic features to the published list of the human atopic" exact="dermatitis" post="like immune or pathophysiological features in the murine model,"/>
  <result pre="valuable for development of preventive or therapeutic medicinal products for" exact="atopic dermatitis." post="ACKNOWLEDGMENTS This study was proceeded as a part of"/>
  <result pre="#20121291). References REFERENCES 1 Weidinger S Novak N 2016 Atopic" exact="dermatitis" post="Lancet 387 1109 1122 10.1016/S0140-6736(15)00149-X 26377142 2 Deckers IA"/>
  <result pre="Janus kinase 3 in NC/Nga mice, a model for human" exact="atopic dermatitis" post="J Immunol 162 1056 1063 9916733 6 Konishi H"/>
  <result pre="kinase 3 in NC/Nga mice, a model for human atopic" exact="dermatitis" post="J Immunol 162 1056 1063 9916733 6 Konishi H"/>
  <result pre="RA 2004 Transgenic mice which overproduces Th2 cytokines develop spontaneous" exact="atopic dermatitis" post="and asthma Int Immunol 16 1150 1160 10.1093/intimm/dxh117 8"/>
  <result pre="2004 Transgenic mice which overproduces Th2 cytokines develop spontaneous atopic" exact="dermatitis" post="and asthma Int Immunol 16 1150 1160 10.1093/intimm/dxh117 8"/>
  <result pre="mice which overproduces Th2 cytokines develop spontaneous atopic dermatitis and" exact="asthma" post="Int Immunol 16 1150 1160 10.1093/intimm/dxh117 8 Chan LS"/>
  <result pre="pruritic inflammatory skin disease: an experimental animal model to study" exact="atopic dermatitis" post="J Invest Dermatol 117 977 983 10.1046/j.0022-202x.2001.01484.x 11676841 9"/>
  <result pre="inflammatory skin disease: an experimental animal model to study atopic" exact="dermatitis" post="J Invest Dermatol 117 977 983 10.1046/j.0022-202x.2001.01484.x 11676841 9"/>
  <result pre="A Horikawa T 2003 DS-Nh as an experimental model of" exact="atopic dermatitis" post="induced by Staphylococcus aureus producing staphylococcal enterotoxin Cell Immunol"/>
  <result pre="Horikawa T 2003 DS-Nh as an experimental model of atopic" exact="dermatitis" post="induced by Staphylococcus aureus producing staphylococcal enterotoxin Cell Immunol"/>
  <result pre="2011 A potential mechanism of 2,4-dinitrochlorobenzene-mediated immune alterations resembling human" exact="atopic dermatitis" post="in mice Quant Bio-Sci 30 85 90 11 Lee"/>
  <result pre="A potential mechanism of 2,4-dinitrochlorobenzene-mediated immune alterations resembling human atopic" exact="dermatitis" post="in mice Quant Bio-Sci 30 85 90 11 Lee"/>
  <result pre="Lee SH Baek SJ Kim HA Heo Y 2006 2,4-Dinitrochlorobenzene-induced" exact="atopic dermatitis" post="like immune alteration in mice Toxicol Res 22 357"/>
  <result pre="SH Baek SJ Kim HA Heo Y 2006 2,4-Dinitrochlorobenzene-induced atopic" exact="dermatitis" post="like immune alteration in mice Toxicol Res 22 357"/>
  <result pre="132 139 10.1016/S1385-299X(99)00009-4 17 Cabanillas B Novak N 2016 Atopic" exact="dermatitis" post="and filaggrin Curr Opi Immunol 42 1 8 10.1016/j.coi.2016.05.002"/>
  <result pre="Matsunaga MC Yamauchi PS 2016 IL-4 and IL-13 inhibition in" exact="atopic dermatitis" post="J Drugs Dermatol 15 925 929 27537991 19 Dinarello"/>
  <result pre="MC Yamauchi PS 2016 IL-4 and IL-13 inhibition in atopic" exact="dermatitis" post="J Drugs Dermatol 15 925 929 27537991 19 Dinarello"/>
  <result pre="epidermal filaggrin reduction and their role in the pathogenesis of" exact="atopic dermatitis" post="J Allergy Clin Immunol 134 792 799 10.1016/j.jaci.2014.06.014 25065719"/>
  <result pre="filaggrin reduction and their role in the pathogenesis of atopic" exact="dermatitis" post="J Allergy Clin Immunol 134 792 799 10.1016/j.jaci.2014.06.014 25065719"/>
  <result pre="FJH Bos JD Kezic S 2013 Filaggrin los-of-function mutations and" exact="atopic dermatitis" post="as risk factors for hand eczema in apprentice nurses:"/>
  <result pre="Bos JD Kezic S 2013 Filaggrin los-of-function mutations and atopic" exact="dermatitis" post="as risk factors for hand eczema in apprentice nurses:"/>
  <result pre="filaggrin in chronic idiopathic urticarial is associated with severity of" exact="urticaria" post="Ann Allergy Asthma Immunol 112 533 538 10.1016/j.anai.2014.03.016 24726196"/>
  <result pre="New insights into T cells and their signature cytokines in" exact="atopic dermatitis" post="IUBMB 67 601 610 10.1002/iub.1405 29 Lee J Cho"/>
  <result pre="insights into T cells and their signature cytokines in atopic" exact="dermatitis" post="IUBMB 67 601 610 10.1002/iub.1405 29 Lee J Cho"/>
  <result pre="Zhu Z Zheng T 2013 TRPA1-dependent pruritis in IL-13-induced chronic" exact="atopic dermatitis" post="J Immunol 191 5371 5382 10.4049/jimmunol.1300300 24140646 Fig. 1"/>
  <result pre="Z Zheng T 2013 TRPA1-dependent pruritis in IL-13-induced chronic atopic" exact="dermatitis" post="J Immunol 191 5371 5382 10.4049/jimmunol.1300300 24140646 Fig. 1"/>
  <result pre="tissue is enhanced in the mice treated with DNCB for" exact="atopic dermatitis" post="induction compared with the vehicle control or the normal"/>
  <result pre="is enhanced in the mice treated with DNCB for atopic" exact="dermatitis" post="induction compared with the vehicle control or the normal"/>
  <result pre="transcript is downregulated in the mice treated with DNCB for" exact="atopic dermatitis" post="induction compared with the vehicle control or the normal"/>
  <result pre="is downregulated in the mice treated with DNCB for atopic" exact="dermatitis" post="induction compared with the vehicle control or the normal"/>
 </snippets>
</snippetsTree>
